Symptoms
Common signs and symptoms of Respiratory Syncytial Virus (RSV) Infection include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Respiratory Syncytial Virus (RSV) Infection.
RSV belongs to the pneumovirus family and spreads primarily through respiratory droplets when infected people cough, sneeze, or talk.
RSV belongs to the pneumovirus family and spreads primarily through respiratory droplets when infected people cough, sneeze, or talk. The virus can also live on surfaces like doorknobs, toys, and countertops for several hours, making indirect transmission common when people touch contaminated surfaces and then touch their face. Think of RSV as particularly social - it thrives in group settings where people are in close contact, which explains why outbreaks frequently occur in daycare centers, schools, and nursing homes.
Once RSV enters the body through the nose, mouth, or eyes, it targets the respiratory tract and begins multiplying in the cells lining the airways.
Once RSV enters the body through the nose, mouth, or eyes, it targets the respiratory tract and begins multiplying in the cells lining the airways. The virus has a special affinity for the bronchioles, the smallest air passages in the lungs. As it replicates, it causes inflammation and swelling of these tiny airways, along with increased mucus production. In larger airways, this might cause only mild congestion, but in the narrow bronchioles of infants, even small amounts of swelling can significantly obstruct airflow.
The virus typically has an incubation period of four to six days, meaning symptoms usually appear within a week of exposure.
The virus typically has an incubation period of four to six days, meaning symptoms usually appear within a week of exposure. People remain contagious for three to eight days, though infants and those with compromised immune systems may shed the virus for several weeks. RSV shows seasonal patterns in most climates, with activity typically beginning in fall, peaking in winter, and tapering off in spring, though timing can vary by geographic location and year.
Risk Factors
- Age under 12 months, especially under 6 months
- Premature birth (born before 37 weeks)
- Chronic lung disease or congenital heart disease
- Compromised immune system
- Age over 65 years
- Attendance at daycare or having school-age siblings
- Exposure to tobacco smoke
- Living in crowded conditions
- Born during RSV season (fall through spring)
- Neuromuscular disorders affecting ability to clear secretions
Diagnosis
How healthcare professionals diagnose Respiratory Syncytial Virus (RSV) Infection:
- 1
Doctors often diagnose RSV based on symptoms, physical examination, and the time of year, since the virus follows predictable seasonal patterns.
Doctors often diagnose RSV based on symptoms, physical examination, and the time of year, since the virus follows predictable seasonal patterns. During RSV season, a young child presenting with characteristic symptoms like runny nose, cough, and breathing difficulties often receives a clinical diagnosis without specific testing. However, when confirmation is needed - particularly for hospitalized patients or those at high risk - several testing options are available.
- 2
The most common diagnostic tests include rapid antigen tests and RT-PCR (reverse transcription polymerase chain reaction) tests, both performed using nasal swab samples.
The most common diagnostic tests include rapid antigen tests and RT-PCR (reverse transcription polymerase chain reaction) tests, both performed using nasal swab samples. Rapid tests provide results within 15-30 minutes but are less sensitive than PCR tests, which take longer but offer greater accuracy. PCR testing has become the gold standard for RSV detection, especially in hospital settings where precise diagnosis affects treatment decisions and infection control measures.
- 3
Doctors also evaluate breathing patterns, oxygen levels, and overall appearance when assessing RSV severity.
Doctors also evaluate breathing patterns, oxygen levels, and overall appearance when assessing RSV severity. They listen for wheezing, check for retractions (skin pulling in around the ribs during breathing), and may measure blood oxygen saturation using a pulse oximeter. Chest X-rays are sometimes ordered to rule out pneumonia or other complications, though they're not routinely needed for straightforward RSV cases. The combination of clinical presentation, physical findings, and targeted testing helps healthcare providers distinguish RSV from other respiratory viruses and determine the most appropriate level of care.
Complications
- Most people recover from RSV without lasting effects, but complications can occur, particularly in high-risk groups.
- Bronchiolitis represents the most common complication in infants, occurring when RSV causes severe inflammation and mucus buildup in the small airways of the lungs.
- This can lead to significant breathing difficulties requiring hospitalization, with some infants needing oxygen support or even mechanical ventilation in intensive care settings.
- Pneumonia develops in some RSV cases when the infection spreads deeper into lung tissue, and secondary bacterial infections can occasionally follow the initial viral infection.
- Severe RSV in infancy has been linked to increased risk of developing asthma later in childhood, though researchers continue studying this connection.
- In adults over 65, RSV can exacerbate existing conditions like chronic obstructive pulmonary disease (COPD) or congestive heart failure, potentially leading to serious complications.
- Dehydration from poor feeding and increased fluid losses through rapid breathing represents another concern, particularly in infants who may require intravenous fluid support.
- While death from RSV is rare, it can occur in very high-risk patients, emphasizing the importance of close monitoring and appropriate medical care for vulnerable populations.
Prevention
- Preventing RSV relies heavily on good hygiene practices and reducing exposure to the virus, especially during peak season from fall through spring.
- Hand hygiene stands as the single most effective prevention strategy - washing hands frequently with soap and water for at least 20 seconds, or using alcohol-based hand sanitizer when soap isn't available.
- This becomes particularly crucial after being in public spaces, before eating, and before touching your face.
- For families with high-risk infants, additional precautions can significantly reduce exposure risk.
- These include limiting visitors during RSV season, avoiding crowded places when possible, keeping infants away from anyone showing cold symptoms, and ensuring all family members practice excellent hand hygiene.
- Daycare attendance presents challenging decisions for parents of high-risk children, as these settings facilitate RSV transmission, yet many families depend on childcare for work obligations.
- Vaccination represents an exciting new prevention tool, with RSV vaccines now approved for pregnant people and adults over 60.
- Maternal RSV vaccination during pregnancy (administered between 32-36 weeks) helps protect newborns during their most vulnerable first months by transferring protective antibodies.
- The CDC also recommends RSV vaccination for adults 60 and older, who can discuss timing with their healthcare providers.
- For very high-risk infants, palivizumab injections provide passive immunity but require monthly administration and are reserved for specific medical criteria due to cost considerations.
RSV treatment focuses primarily on supportive care, as no specific antiviral medications are widely available for routine use.
RSV treatment focuses primarily on supportive care, as no specific antiviral medications are widely available for routine use. The goal is to help patients stay comfortable and maintain adequate breathing and hydration while their immune system fights off the virus. For most healthy children and adults, home care with rest, fluids, and symptom management proves sufficient for recovery within one to two weeks.
At home, treatment strategies include using a cool-mist humidifier to ease breathing, ensuring adequate fluid intake to prevent dehydration, and providing appropriate fever management with acetaminophen or ibuprofen as directed by age guidelines.
At home, treatment strategies include using a cool-mist humidifier to ease breathing, ensuring adequate fluid intake to prevent dehydration, and providing appropriate fever management with acetaminophen or ibuprofen as directed by age guidelines. Saline nose drops followed by gentle suctioning can help clear nasal congestion in infants who cannot blow their own noses. Parents should never give aspirin to children due to the risk of Reye's syndrome, and over-the-counter cough and cold medications are not recommended for children under two years old.
Hospitalization becomes necessary for patients with severe RSV, particularly infants showing signs of respiratory distress, dehydration, or inability to feed.
Hospitalization becomes necessary for patients with severe RSV, particularly infants showing signs of respiratory distress, dehydration, or inability to feed. Hospital treatments may include: - Supplemental oxygen therapy - Intravenous fluids for hydration - Respiratory support ranging from high-flow nasal cannula to mechanical ventilation in severe cases - Careful monitoring of breathing, oxygen levels, and feeding
Ribavirin, an antiviral medication, is occasionally used in very high-risk patients, though its use remains limited due to cost, complexity of administration, and questions about effectiveness.
Ribavirin, an antiviral medication, is occasionally used in very high-risk patients, though its use remains limited due to cost, complexity of administration, and questions about effectiveness. Recent research has focused on developing new antiviral treatments specifically for RSV, with some promising candidates in clinical trials. Preventive treatment with palivizumab (Synagis), a monoclonal antibody, is available for very high-risk infants, though it requires monthly injections throughout RSV season and is reserved for specific medical criteria due to its high cost.
Living With Respiratory Syncytial Virus (RSV) Infection
Managing RSV at home requires careful attention to symptoms while providing comfort measures that support recovery. Creating a comfortable environment helps patients rest and heal - this includes maintaining adequate humidity levels, ensuring good ventilation, and keeping the home free from tobacco smoke and other irritants. For parents caring for infants with RSV, frequent small feedings often work better than regular-sized bottles or nursing sessions, as babies may tire easily or have trouble breathing while feeding.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Mar 16, 2026v1.0.0
- Published page overview and treatments by DiseaseDirectory